Signal averaged ECG in different patterns of left ventricular hypertrophy and geometry in hypertension

Andrzej Wojszwiłło1, Krystyna Łoboz-Grudzień, Joanna Jaroch

  • 1Department of Cardiology T. Marciniak Hospital, Wroclaw, Poland.

Kardiologia Polska
|October 3, 2003
PubMed

Insights

Ventricular late potentials (LP) are more common in hypertensive patients with left ventricular hypertrophy (LVH), especially eccentric hypertrophy. Structural heart changes and reduced parasympathetic activity significantly influence LP occurrence in hypertension.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Hypertension Research

Background:

  • The determinants of ventricular late potentials (LP) in hypertensive patients remain unclear.
  • Understanding these factors is crucial for risk stratification and management.

Purpose of the Study:

  • To investigate the prevalence of LP in hypertension.
  • To correlate LP with left ventricular hypertrophy (LVH) patterns and geometry.
  • To identify factors contributing to signal-averaged ECG abnormalities.

Main Methods:

  • 109 hypertensive patients without coronary artery disease underwent 2D Echo Doppler, 24-hr Holter, signal-averaged ECG, and heart rate variability (HRV) analysis.
  • Patients were categorized into four LVH geometry patterns: normal, concentric remodeling, concentric hypertrophy, and eccentric hypertrophy.
  • Statistical analyses included linear regression and univariate/multivariate assessments.

Main Results:

  • LP were more frequent in patients with LVH (9.1%) compared to those without (5.6%), particularly in eccentric hypertrophy.
  • Significant correlations were found between LV mass/volume and late QRS potentials (LAS, V40).
  • Heart rate variability indices (LF/HF ratio) correlated with signal-averaged ECG parameters, and reduced parasympathetic activity was linked to LP.

Conclusions:

  • Hypertensive patients with LVH, especially eccentric hypertrophy, show a higher incidence of LP.
  • Left ventricular structural remodeling and parasympathetic withdrawal are significant determinants of LP.
  • While associated, these factors were not independent predictors in multivariate analysis.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...